ANTARES PHARMA, INC. reports

Company location: Ewing, NJ
Fiscal year end: 31 December

ANTARES PHARMA, INC. has filed 1,187 SEC EDGAR filings since 24 Jun 1996

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 576-600 of 688 matching filings.

Per page

25

Current page

24

8-K File 001-32302

FORM 8-K

Filing date: 04 Oct 2012
Reporting date: 03 Oct 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

424B2 File 333-167975

424B2

Filing date: 03 Oct 2012
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

424B2 File 333-167975

PRELIMINARY PROSPECTUS SUPPLEMENT

Filing date: 02 Oct 2012
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

GARRITY FORM 4 PART 3

Filing date: 22 Aug 2012
Reporting date: 20 Aug 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4

GARRITY AUGUST 2012 PART 2

Filing date: 22 Aug 2012
Reporting date: 20 Aug 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4

GARRITY AUGUST 2012

Filing date: 22 Aug 2012
Reporting date: 20 Aug 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-32302

FORM 10-Q

Filing date: 08 Aug 2012
Reporting date: 30 Jun 2012
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-32302

FORM 8-K

Filing date: 12 Jul 2012
Reporting date: 06 Jul 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4

KAUSHIK JULY 6 FORM 4

Filing date: 10 Jul 2012
Reporting date: 06 Jul 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4

BOB JULY 6 FORM 4

Filing date: 10 Jul 2012
Reporting date: 06 Jul 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PAUL JULY 6 FORM 4

Filing date: 10 Jul 2012
Reporting date: 06 Jul 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4/A

4/A filing

Filing date: 29 Jun 2012
Reporting date: 17 May 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

25 File 001-32302

FORM 25

Filing date: 26 Jun 2012
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-A12B File 001-32302

FORM 8-A

Filing date: 13 Jun 2012
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-32302

FORM 8-K

Filing date: 11 Jun 2012
Reporting date: 06 Jun 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 31 May 2012
Reporting date: 29 May 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 31 May 2012
Reporting date: 29 May 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-32302

ANTARES PHARMA, INC 8-K 5-17-2012

Filing date: 23 May 2012
Reporting date: 17 May 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 21 May 2012
Reporting date: 17 May 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 21 May 2012
Reporting date: 17 May 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 21 May 2012
Reporting date: 17 May 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 21 May 2012
Reporting date: 17 May 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 21 May 2012
Reporting date: 17 May 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 21 May 2012
Reporting date: 17 May 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 21 May 2012
Reporting date: 17 May 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .